Detalhe da pesquisa
1.
A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor.
Blood
; 120(13): 2723-32, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915646
2.
Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
Blood
; 115(23): 4870-7, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20200350
3.
Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa.
Blood
; 112(3): 603-9, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18487513
4.
Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.
Arterioscler Thromb Vasc Biol
; 28(3): 419-24, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18187670
5.
Role of von Willebrand factor in tumor metastasis.
Thromb Res
; 120 Suppl 2: S64-70, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18023715
6.
Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF.
Blood
; 109(5): 2267-8, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17312004